In vivo Evaluation of Free and Chelated Accelerator-produced Actinium- 225 - Radiation Dosimetry and Toxicity Results

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|11|3|215-222

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.11, Iss.3, 2018-12, pp. : 215-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 306-320

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 192-199

Bentham Science Publishers

Access to resources Recommend Favorite

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 180-191

Bentham Science Publishers

Access to resources Recommend Favorite